Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome

Calmarza, Pilar; Lapresta, Carlos; Martínez, María; Lahoz, Raquel; Povar, Javier.
Arch. cardiol. Méx ; 88(5): 391-396, dic. 2018. graf
Artículo en Inglés | LILACS | ID: biblio-1142148

Documentos relacionados

  1. Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
  2. From Suspicion to Recognition-Being a Bystander to a Relative Affected by Acute Coronary Syndrome.
  3. Whats new in 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST segment elevation?
  4. Symptom recognition and treatment-seeking behaviors in women experiencing acute coronary syndrome for the first time: a qualitative study.
  5. A Machine Learning-Based Applied Prediction Model for Identification of Acute Coronary Syndrome (ACS) Outcomes and Mortality in Patients during the Hospital Stay.
  6. Participation and Prognostic Impact of Cardiac Rehabilitation After Acute Coronary Syndrome: Big-Data Study of the Korean National Health Insurance Service.
  7. Sex, Racial, and Ethnic Disparities in Acute Coronary Syndrome: Novel Risk Factors and Recommendations for Earlier Diagnosis to Improve Outcomes.
  8. Pseudo precordial ST-segment depression.
  9. Outcomes in patients with chest pain in emergency departments using high-sensitivity versus conventional troponins.
  10. [Guidelines for the management of non-ST elevation acute coronary syndromes (2024)].